Page 5 - Drug Pricing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up with the announcement of a hearing this summer to consider administrative penalties against AstraZeneca Pharmaceuticals LP, the drug manufacturing giant that filed a lawsuit against the state earlier this year over Act 1103 of 2021 -- the 340B Drug Pricing Nondiscrimination Act.

I’m a patient who, like many other patients, is sharing my story of how 340B benefitted me.

The 340B Drug Pricing Program was intended to help our most vulnerable citizens access medicines and care when they are sick

The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.

Performance Reflects Execution and Actions to Strengthen the Company's Long-Term Growth Profile First Quarter Revenues were $11.9 Billion, increasing 5% Growth Portfolio Revenues were $4.8...